2023
|
Invention
|
M971 chimeric antigen receptors.
The invention provides a chimeric antigen receptor (CAR) compri... |
|
Invention
|
Powered gait assistance systems.
Disclosed are powered gait assistance systems that include a co... |
|
Invention
|
Engineered sars-cov-2 antibodies with increased neutralization breadth. Disclosed are monoclonal ... |
|
Invention
|
Single domain antibodies targeting hpv e6/e7 oncogenic peptide/mhc complexes. HHH) antibody libra... |
|
Invention
|
Vaccines against coronaviruses. The present disclosure relates to the field of vaccines and bindi... |
|
Invention
|
Synergistic interactions for improved cancer treatment. This disclosure provides compositions and... |
|
Invention
|
Systems and methods for electrocardiographic radial depth navigation of intracardiac devices. Var... |
|
Invention
|
Surgical tool and method for soft ocular tissue transplantation.
Disclosed are devices and metho... |
|
Invention
|
Dual-germline antibody engager hiv-1 envelope chimeric immunogens. The invention provides an HIV-... |
|
Invention
|
Halophthalimide compounds and methods of use against tbi, inflammatory disorder, autoimmune disor... |
|
Invention
|
Multi-cyclic irak1 and irak4 inhibiting compounds and uses thereof. The present disclosure provid... |
|
Invention
|
Monoclonal antibodies that bind to the underside of influenza viral neuraminidase. Monoclonal ant... |
|
Invention
|
Selective opioid receptor agonists and antagonists. Compounds having opioid characteristics are p... |
|
Invention
|
Method of immmunofocusing an immune response. The present disclosure relates to vaccines, therape... |
|
Invention
|
Kinase inhibitors. Disclosed is a class of kinase inhibitors. Related pharmaceutical compositions... |
|
Invention
|
Compositions and methods for treatment of virus-induced airway fibrosis. Methods of treating or i... |
|
Invention
|
Impeding platinum-based chemotherapeutic induced ototoxicity using a colony stimulating factor 1 ... |
|
Invention
|
Very-long-chain polyunsaturated fatty acids (vlcpufa) for improving retina/cognitive functions an... |
|
Invention
|
Cell-barcode recorder devices and methods. In aspects, the disclosure provides devices and method... |
|
Invention
|
Methods and compositions for improving wound healing. The present disclosure relates to compositi... |
|
Invention
|
Anti-sars-cov-2 antigen binding polypeptides, polypeptide complexes and methods of use thereof. D... |
|
Invention
|
Cd25-specific antibodies and uses thereof. Monoclonal antibodies that specifically bind CD25, as ... |
|
Invention
|
Augmenting mitochondria in immune cells for improved cancer immunotherapy. The present invention ... |
|
Invention
|
Immunogens and methods for inducing an immune response. This disclosure generally relates to meth... |
|
Invention
|
Multi-cyclic irak and flt3 inhibiting compounds and uses thereof. Some embodiments of the disclos... |
|
Invention
|
Viral strain serology assays. The invention relates to methods and kits for determining a SARS-Co... |
|
Invention
|
Echocardiographic estimation of right atrial pressure using a lightweight and open-world artifici... |
|
Invention
|
Computationally engineered monocolonal antibodies and antigen binding fragments specific for sars... |
|
Invention
|
Compositions, systems, and methods for delivery of therapeutics. The present disclosure provides ... |
|
Invention
|
Compounds for inhibiting gram-positive bacteria. Compounds and methods for their use in inhibitin... |
|
Invention
|
Compositions and methods for pharmacologic treatment of stroke and myocardial ischemia reperfusio... |
|
Invention
|
Predicting patient response to cancer therapy via histopathology images. A method of training an ... |
|
Invention
|
Engineered cell-penetrating antiviral compound. Compounds for inhibiting the replication of intra... |
|
Invention
|
Live-attenuated sars-cov-2 vaccine. Engineered SARS-CoV-2 variants having a combination of attenu... |
|
Invention
|
Compositions and methods for detecting lymphatic filariasis. ,, are provided, including the antig... |
|
Invention
|
E. coli. E. colilac E. coliE. coliE. coli. |
|
Invention
|
Replicating rna vaccine for crimean-congo hemorrhagic fever virus. Described herein are construct... |
|
Invention
|
Pim-targeted protacs with pim-binding moieties sgi-1776, azd-1208 or pim-447, and a e3 ubiquitin ... |
|
Invention
|
Vaccine for human t-lymphotropic virus-1. Provided herein is a nucleic acid-based vaccine for hum... |
|
Invention
|
Systems and method for synchronous circumferential intramyocardial resynchronization and pacing. ... |
|
Invention
|
Modified factor xa polypeptides and methods of use. Modified Factor Xa polypeptides having functi... |
2021
|
Invention
|
Novel var2csa immunogens and methods of use thereof.
The disclosure provides immunogen polypepti... |
|
Invention
|
Tyrosyl-lock peptides.
Disclosed is a class of knotted cyclic peptides. Related pharmaceutical c... |
|
Invention
|
Enhanced antigen reactivity of immune cells expressing a mutant non-signaling cd3 zeta chain.
Di... |
|
Invention
|
Rna sensors and uses thereof.
The invention generally concerns a novel class of cyclopentane mod... |
|
Invention
|
Plk1 polo box domain inhibitors and method of treating cancer.
Provided is a method of treating ... |
|
Invention
|
Novel adeno-associated viral (aav) vectors to treat hereditary methylmalonic acidemia (mma) cause... |